Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -12.03 | 16.25 |
| PEG Ratio (TTM) | 2.65 | 1.70 |
| P/S Ratio (TTM) | 7.46 | 2.61 |
| P/B Ratio (TTM) | 0.72 | 1.90 |
| P/FCF Ratio (TTM) | 260.14 | 11.14 |
| Price to 5YR AVG Earnings Ratio | N/A | 14.10 |
| Price to 5YR AVG FCF Ratio | N/A | 8.07 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.72% | 1,502.82% |
| ROE (TTM) | -5.94% | 8.88% |
| Net Profit Margin (TTM) | -57.81% | 15.60% |
| ROIC 5YR AVG | N/A | 20.57% |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -397.35% | 26.54% | N/A |
| Revenue | 98.74% | 6.63% | N/A |
| Net Income | -386.94% | 24.31% | N/A |
| Cash Flow | 86.91% | 111.00% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.60 | 3.19 |
| Quick Ratio (TTM) | 1.96 | 4.91 |
| D/E Ratio (TTM) | 0.07 | 1.27 |
| Interest Coverage (TTM) | -1.44 | 0.64 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 0.31 | 0.38 |
| LTL to 5YR AVG FCF | N/A | 6.26 |
| Shares Outstanding Growth 5YR AVG | N/A | 4.88% |